The management of chronic obstructive pulmonary disease (COPD) has improved
significantly due to advances in therapeutic agents, but it has also become apparent that …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition, primarily
characterized by the presence of a limited airflow, due to abnormalities of the airways and/or …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It has been projected to move from the sixth to the third most common cause of …

Evidence suggests that systemic inflammation may be the link between COPD and
comorbidities, but this issue is still debated. Whatever the mechanism underlying …

Comorbidities impact a large proportion of patients with chronic obstructive pulmonary
disease (COPD), with over 80% of patients with COPD estimated to have at least one …

Patients with chronic obstructive pulmonary diseases (COPD) often experience comorbid
conditions. The most common comorbidities that have been associated with COPD include …

The classical definition of Chronic Obstructive Pulmonary Disease (COPD) as a lung
condition characterized by irreversible airway obstruction is outdated. The systemic …

In recent years several studies in the field of chronic obstructive pulmonary disease (COPD)
have addressed the impact of comorbidities on the phenotypic presentation of an individual …

Health care utilization and costs associated with chronic obstructive pulmonary disease
(COPD) continue to increase, notwithstanding evidence–based management strategies …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous collection of syndromes
with overlapping manifestations. In the past, this has led to considerable variance in …